Skip to main content
FDA approves topical roflumilast for psoriasis in children aged 6-11
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves topical roflumilast for psoriasis in children aged 6-11
User login
Username
Password
Reset your password
Concept
Lead
score
Psoriasis
1
1
Child
0
0.99
Plaque Psoriasis
0
0.55
Pharmacokinetics
0
0.14
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.8
Rheumatology
0
0.7
Pediatrics
0
0.9
Pharmacist
0
0.6
Edit Tags